Gene Therapy Formulation

Our gene therapy formulation process is seamlessly integrated with downstream and analytical processes to ensure optimal results. We focus on selecting the right buffer and excipient combinations, conducting thorough stability testing, and confirming device compatibility and dosing procedures.

Utilizing low-volume, high-throughput techniques allows us to achieve better outcomes with less material, enhancing efficiency in the development process. We also prioritize rapid rebuffering and analytical testing, leading to shorter development cycles and fewer barriers to reaching the final formulation. Additionally, our collaborative approach to regulatory data documentation and submission ensures smooth and timely progress towards regulatory approval.